Job.com acquired two staffing firms: Fortus Healthcare Resources, which provides direct and travel placement of healthcare professionals; and Endevis, which offers permanent recruitment services, contract staffing and recruitment process outsourcing to the automotive, commercial and manufacturing sectors.
Together, the two businesses will add more than $50 million of annual revenue to Job.com’s cash flow, the company said.Job.com acquired two staffing firms in separate transactions, which will add $50 million to its annual cash flow. #HR #HRTech Click To Tweet
The acquisitions are part of Job.com’s strategic plan to develop its revenue and expand its reach by acquiring businesses that, while successful, have the potential to grow quickly through the application of Job.com’s proprietary technology.
CEO Paul Sloyan said the two companies complement HireVergence, a cybersecurity staffing firm that Job.com acquired in 2020. In the first 12 months of owning HireVergence, Job.com worked with the company to grow the business and nearly double the number of contractors who are billing. “Our goal is to do the same with these two new acquisitions,” Sloyan said.
Job.com uses technology to provide recruiters, candidates and employers with a more seamless job search experience.
Founded in 1993 and based in Utica, N.Y., Fortus serves hospitals and other facilities throughout the U.S., providing nurses and medical professionals on a contract and permanent basis. It currently employs over 200 contract nurses and a team of over 40 recruiters.
Endevis was founded in 2000 and maintains offices in Ohio, Tennessee and New Jersey. Its three divisions offer hiring solutions including contract staffing, direct placement and RPO. It currently employs more than 100 contractors and 60 staff.
Job.com said that together, it, Fortus and Endevis will be able to “exponentialize” the growth experienced by the company’s previous acquisitions.
In the meantime, “we remain very acquisitive and will continue to add more great staffing and HR tech firms to our portfolio in the coming months,” Sloyan said.